Small Molecule Therapeutics
Eribulin Suppresses Clear Cell Sarcoma Growth by Inhibiting Cell Proliferation and Inducing Melanocytic Differentiation Both Directly and Via Vascular Remodeling
Sho Nakai, Hironari Tamiya, Yoshinori Imura, Takaaki Nakai, Naohiro Yasuda, Toru Wakamatsu, Takaaki Tanaka, Hidetatsu Outani, Satoshi Takenaka, Kenichiro Hamada, Akira Myoui, Nobuhito Araki, Takafumi Ueda, Hideki Yoshikawa and Norifumi Naka
Sho Nakai
1Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, Osaka, Japan.
Hironari Tamiya
2Musculoskeletal Oncology Service, Osaka International Cancer Institute, Osaka, Japan.
Yoshinori Imura
2Musculoskeletal Oncology Service, Osaka International Cancer Institute, Osaka, Japan.
Takaaki Nakai
3Department of Orthopaedic Surgery, Kawachi General Hospital, Kawachi, Japan.
Naohiro Yasuda
1Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, Osaka, Japan.
Toru Wakamatsu
2Musculoskeletal Oncology Service, Osaka International Cancer Institute, Osaka, Japan.
Takaaki Tanaka
2Musculoskeletal Oncology Service, Osaka International Cancer Institute, Osaka, Japan.
Hidetatsu Outani
1Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, Osaka, Japan.
Satoshi Takenaka
1Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, Osaka, Japan.
Kenichiro Hamada
1Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, Osaka, Japan.
Akira Myoui
1Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, Osaka, Japan.
Nobuhito Araki
4Department of Orthopaedic Surgery, Ashiya Municipal Hospital, Ashiya, Japan.
Takafumi Ueda
5Department of Orthopaedic Surgery, Osaka National Hospital, Osaka, Japan.
Hideki Yoshikawa
1Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, Osaka, Japan.
Norifumi Naka
1Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, Osaka, Japan.
2Musculoskeletal Oncology Service, Osaka International Cancer Institute, Osaka, Japan.
DOI: 10.1158/1535-7163.MCT-19-0358 Published March 2020

Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
March 2020
Volume 19, Issue 3
Volume 19, Issue 3
Eribulin Suppresses Clear Cell Sarcoma Growth by Inhibiting Cell Proliferation and Inducing Melanocytic Differentiation Both Directly and Via Vascular Remodeling
Sho Nakai, Hironari Tamiya, Yoshinori Imura, Takaaki Nakai, Naohiro Yasuda, Toru Wakamatsu, Takaaki Tanaka, Hidetatsu Outani, Satoshi Takenaka, Kenichiro Hamada, Akira Myoui, Nobuhito Araki, Takafumi Ueda, Hideki Yoshikawa and Norifumi Naka
Mol Cancer Ther March 1 2020 (19) (3) 742-754; DOI: 10.1158/1535-7163.MCT-19-0358
Eribulin Suppresses Clear Cell Sarcoma Growth by Inhibiting Cell Proliferation and Inducing Melanocytic Differentiation Both Directly and Via Vascular Remodeling
Sho Nakai, Hironari Tamiya, Yoshinori Imura, Takaaki Nakai, Naohiro Yasuda, Toru Wakamatsu, Takaaki Tanaka, Hidetatsu Outani, Satoshi Takenaka, Kenichiro Hamada, Akira Myoui, Nobuhito Araki, Takafumi Ueda, Hideki Yoshikawa and Norifumi Naka
Mol Cancer Ther March 1 2020 (19) (3) 742-754; DOI: 10.1158/1535-7163.MCT-19-0358
Jump to section
Advertisement